Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

FIT free lunch

Dec. 4, 2018

SNACing on peptides: findings may allow oral delivery of peptides

Nov. 20, 2018

Template-free Cas9 for accurate editing

Nov. 14, 2018

Sosei collaborates with DyNAbind to accelerate GPCR drug discovery

Nov. 7, 2018

Enesi and Sementis collaborate on solid dose vaccine development

Nov. 7, 2018

CRISPR bad news, but with a fix

Nov. 7, 2018

Drugging "undruggable" zinc fingers

Nov. 5, 2018

Uniparental mice give insights into ESC imprinting

Oct. 29, 2018

Alexion and Dicerna collaborate on RNAi therapies for complement-mediated diseases

Oct. 25, 2018

Methionine manipulation expands protein toolbox

Oct. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...